BioSpace News Archive

Seventh annual summit spotlights the push to prioritize community health at the national and local level

Expands Ipsen’s Rare Diseases portfolio to include BLU-782, a highly selective investigational ALK2 inhibitor for the treatment of FOP

Funding will support development of Credence’s Dual Chamber Reconstitution Syringe

Bertin Energy & Environment is supported by the French private sector research and assistance fund to study possible energy supply solutions for the South African part of this large radio telescope.

The MS MindShift: A New View of MS initiative from Celgene Corporation and the Multiple Sclerosis Association of America is making its third stop at the Owl-O-Ween Hot Air Balloon Festival in Kennesaw, Ga., on October 18 and 19.

Insilico Medicine and ChemDiv, Inc. launched a new strategic collaboration to provide certain pharmaceutical and biotechnology companies with end-to-end drug discovery solutions.

Company makes Dow Jones Sustainability Indices for the third time

AURORA Phase 3 results with voclosporin for the treatment of lupus nephritis remain on track to be reported by the end of the fourth quarter 2019

D-PLEX100 Administration into the Surgical Site Led to Statistically Significant Reduction in Infections Compared to Standard of Care Alone

Emerald Health Therapeutics’ wholly-owned production facility, Verdélite, in St. Eustache, Québec, has received from Health Canada its license amendment permitting it to sell and distribute packaged, branded dried cannabis products directly to provincial/territorial wholesalers and authorized private retailers in accordance with provincial/territorial frameworks in Canada.